Thermal susceptibility and antibiotic synergism of methicillin-resistant Staphylococcus aureus biofilms

Area of Science:

• Microbiology
• Biomedical Engineering
• Infectious Diseases

Background:

• Methicillin-Resistant Staphylococcus aureus (MRSA) biofilms pose significant threats to medical implants, often necessitating device removal.
• Current treatments for MRSA implant infections are limited and frequently require invasive surgical intervention.

Purpose of the Study:

• To investigate the thermal susceptibility of MRSA biofilms to varying heat shocks (60-80°C for 1-30 min).
• To evaluate the impact of antibiotic pre- and post-treatment on thermal mitigation of MRSA biofilms.
• To explore synergistic effects between thermal therapy and antibiotics against MRSA biofilms.

Main Methods:

• MRSA biofilms were subjected to thermal shocks ranging from 60 to 80°C for durations of 1 to 30 minutes.
• Biofilms were exposed to antibiotics (ciprofloxacin, tobramycin, methicillin) at concentrations from 0.25 to 128 µg/mL before and after thermal shock.
• Biofilm viability was assessed post-treatment to determine the effectiveness of combined therapies.

Main Results:

• MRSA biofilms demonstrated thermal susceptibility, comparable to other nosocomial pathogens like Pseudomonas aeruginosa.
• Antibiotic exposure, even at subclinical concentrations, significantly reduced the required thermal shock intensity for biofilm mitigation.
• Combined thermal and antibiotic treatments exhibited synergistic effects, achieving greater biofilm reduction than either modality alone.
• A critical population reduction of approximately 4.5 log10 was identified as a threshold for biofilm non-viability.

Conclusions:

• Thermal therapy is a viable strategy for reducing MRSA biofilm viability.
• Combining thermal shock with antibiotic treatment offers a synergistic approach to eradicate MRSA biofilms, potentially improving outcomes for infected medical implants.
• This combined approach may reduce the need for surgical explantation in certain MRSA biofilm infections.